DNA from Mycobacterium bovis bacillus Calmette-Guerin (MY-1) inhibits immunoglobulin E production by human lymphocytes

Citation
S. Fujieda et al., DNA from Mycobacterium bovis bacillus Calmette-Guerin (MY-1) inhibits immunoglobulin E production by human lymphocytes, AM J R CRIT, 160(6), 1999, pp. 2056-2061
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","da verificare
Journal title
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN journal
1073449X → ACNP
Volume
160
Issue
6
Year of publication
1999
Pages
2056 - 2061
Database
ISI
SICI code
1073-449X(199912)160:6<2056:DFMBBC>2.0.ZU;2-G
Abstract
A DNA fraction purified from Mycobacterium bovis bacillus Calmette-Guerin ( BCC) and designated MY-1 induced interferon (IFN)-gamma production by human peripheral blood mononuclear cells (PBMC). IFN-gamma is well known as a do wnregulator of IgE production. In this study we investigated whether MY-1 r egulates IgE production by human PBMC in vitro. MY-1 inhibited IgE producti on in PBMC taken from normal donors and stimulated with interleukin (IL)-4 plus monoclonal anti-CD40 antibody, without affecting production of IgA. MY -1 enhanced production of IFN-gamma and IL-12 by PBMC. Inhibition by MY-1 o f IgE production was mediated by both IFN-gamma and IL-12, since the MY-1-i nduced suppression was blocked by the addition of monoclonal anti-IFN-gamma antibody, monoclonal anti-IL-12 antibody or a monoclonal antibody (mAb) di rected at the IL-12 receptor. MY-1 inhibited the induction of epsilon germ- line transcript by IL-4. Additionally, MY-1 inhibited spontaneous in vitro production of IgE by PBMC from atopic donors in the absence of IL-4 plus an ti-CD40 mAb, These results suggest that exposure to MY-1 may be a novel str ategy for the treatment of IgE-related allergic disease.